BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25567655)

  • 1. Sorcin Enhances Metastasis and Promotes Epithelial-to-Mesenchymal Transition of Colorectal Cancer.
    Tong W; Sun D; Wang Q; Suo J
    Cell Biochem Biophys; 2015 Jun; 72(2):453-9. PubMed ID: 25567655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
    Wang F; Ruan XJ; Zhang HY
    Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.
    Zhao GX; Xu YY; Weng SQ; Zhang S; Chen Y; Shen XZ; Dong L; Chen S
    Oncogene; 2019 Jun; 38(23):4574-4589. PubMed ID: 30742066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
    Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
    Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.
    Tan X; Chen S; Wu J; Lin J; Pan C; Ying X; Pan Z; Qiu L; Liu R; Geng R; Huang W
    Cell Death Dis; 2017 Mar; 8(3):e2686. PubMed ID: 28300833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.
    Chen H; Liu Y; Jiang CJ; Chen YM; Li H; Liu QA
    Med Sci Monit; 2019 Jun; 25():4176-4185. PubMed ID: 31164625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
    Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
    J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of intravenous anesthetics in colorectal cancer progression: implications for clinical application.
    Deng F; Ouyang M; Wang X; Yao X; Chen Y; Tao T; Sun X; Xu L; Tang J; Zhao L
    Oncotarget; 2016 Nov; 7(47):77087-77095. PubMed ID: 27780923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
    Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H
    Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOR promotes epithelial-mesenchymal transition and proliferation via PI3K/AKT signaling pathway in human colorectal cancer.
    Gao L; Yang L; He Y; Liu Y; Xu P; Zhang J; Dai S; Luo X; Sun Z
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 55(1):72-80. PubMed ID: 35983971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen facilitates the colorectal cancer stemness and metastasis through an integrin/PI3K/AKT/Snail signaling pathway.
    Wu X; Cai J; Zuo Z; Li J
    Biomed Pharmacother; 2019 Jun; 114():108708. PubMed ID: 30913493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway.
    Yu J; Liu M; Liu H; Zhou L
    Mol Cell Biochem; 2019 Jul; 457(1-2):191-199. PubMed ID: 31069596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorooctane sulfonate promotes the migration of colorectal cancer cells by inducing epithelial-mesenchymal transition.
    Li F; Chen L; Peng BX; Lei Y; Li M; Guo LH
    J Environ Sci (China); 2024 Nov; 145():1-12. PubMed ID: 38844310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
    Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
    Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
    Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.